Cyclo Therapeutics Inc (CYTH)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
May 14, 16:00
1.43
+0.02
(+1.42%)
After-Hours: 20:00
Cyclo Therapeutics Gross Profit Margin (Quarterly): 95.02% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 95.02% |
| September 30, 2023 | 92.18% |
| June 30, 2023 | 83.00% |
| March 31, 2023 | 93.31% |
| December 31, 2022 | 91.56% |
| September 30, 2022 | 92.69% |
| June 30, 2022 | 86.41% |
| March 31, 2022 | 91.55% |
| December 31, 2021 | 88.27% |
| September 30, 2021 | 94.39% |
| June 30, 2021 | 87.36% |
| March 31, 2021 | 90.34% |
| December 31, 2020 | 89.39% |
| September 30, 2020 | 94.80% |
| June 30, 2020 | 93.82% |
| March 31, 2020 | 91.89% |
| December 31, 2019 | 94.43% |
| September 30, 2019 | 90.92% |
| June 30, 2019 | 94.03% |
| March 31, 2019 | 90.69% |
| December 31, 2018 | 94.04% |
| September 30, 2018 | 94.19% |
| June 30, 2018 | 84.53% |
| March 31, 2018 | 88.05% |
| December 31, 2017 | 91.18% |
| Date | Value |
|---|---|
| September 30, 2017 | 91.85% |
| June 30, 2017 | 84.89% |
| March 31, 2017 | 93.65% |
| December 31, 2016 | 85.87% |
| September 30, 2016 | 88.90% |
| June 30, 2016 | 85.39% |
| March 31, 2016 | 88.22% |
| December 31, 2015 | 88.08% |
| September 30, 2015 | 89.25% |
| June 30, 2015 | 84.91% |
| March 31, 2015 | 87.03% |
| December 31, 2014 | 70.53% |
| September 30, 2014 | 88.04% |
| June 30, 2014 | 86.77% |
| March 31, 2014 | 78.51% |
| December 31, 2013 | 84.80% |
| September 30, 2013 | 82.61% |
| June 30, 2013 | 79.46% |
| March 31, 2013 | 63.01% |
| December 31, 2012 | |
| September 30, 2012 | 85.25% |
| June 30, 2012 | 84.32% |
| March 31, 2012 | 75.21% |
| December 31, 2011 | 94.15% |
| September 30, 2011 | 84.10% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
83.00%
Minimum
Jun 2023
95.02%
Maximum
Dec 2023
91.33%
Average
91.89%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 68.19% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.99K% |
| Return on Assets | -315.4% |
| Return on Invested Capital | -3.99K% |
| Profit Margin (Quarterly) | -1.81K% |
| Operating Margin (Quarterly) | -1.81K% |
| Return on Net Operating Assets | -375.6% |